Sandler Capital Management Biolife Solutions Inc Transaction History

Sandler Capital Management

$698 Million
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$20.81 - $37.29 $1.22 Million - $2.19 Million	-58,761 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$32.99 - $58.55 $1.49 Million - $2.65 Million	-45,271 Reduced 43.52%	58,761 $2.19 Million
Q3 2021 Nov 15, 2021	SELL	$42.03 - $60.5 $5 Million - $7.19 Million	-118,890 Reduced 53.33%	104,032 $4.4 Million
Q2 2021 Aug 16, 2021	BUY	$29.51 - $44.62 $1.14 Million - $1.73 Million	38,780 Added 21.06%	222,922 $9.92 Million
Q1 2021 May 17, 2021	SELL	$32.95 - $44.24 $1.13 Million - $1.52 Million	-34,310 Reduced 15.71%	184,142 $6.63 Million
Q3 2020 Nov 16, 2020	BUY	$16.04 - $28.94 $224,752 - $405,507	14,012 Added 6.85%	218,452 $6.32 Million
Q2 2020 Aug 14, 2020	SELL	$9.2 - $17.06 $1.95 Million - $3.62 Million	-212,450 Reduced 50.96%	204,440 $3.34 Million
Q1 2020 May 15, 2020	SELL	$8.36 - $17.03 $1.26 Million - $2.57 Million	-150,878 Reduced 26.57%	416,890 $3.96 Million
Q4 2019 Feb 14, 2020	SELL	$14.59 - $18.9 $875,400 - $1.13 Million	-60,000 Reduced 9.56%	567,768 $9.19 Million
Q3 2019 Nov 14, 2019	SELL	$15.7 - $20.98 $3.77 Million - $5.04 Million	-240,000 Reduced 27.66%	627,768 $10.4 Million
Q2 2019 Aug 14, 2019	SELL	$15.2 - $19.42 $1.52 Million - $1.95 Million	-100,305 Reduced 10.36%	867,768 $14.7 Million
Q4 2018 Feb 14, 2019	BUY	$9.5 - $17.17 $1.75 Million - $3.16 Million	184,253 Added 23.51%	968,073 $11.6 Million
Q3 2018 Nov 14, 2018	BUY	$14.99 - $25.48 $9.49 Million - $16.1 Million	632,780 Added 418.95%	783,820 $13.7 Million
Q2 2018 Aug 14, 2018	BUY	$6.18 - $13.49 $933,427 - $2.04 Million	151,040 New	151,040 $1.72 Million

Others Institutions Holding BLFS

# of Institutions

198

Shares Held

44.9M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.17B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandler Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Sandler Capital Management with notifications on news.

Account